Home Cart Sign in  
Chemical Structure| 161796-78-7 Chemical Structure| 161796-78-7

Structure of Esomeprazole sodium
CAS No.: 161796-78-7

Chemical Structure| 161796-78-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Esomeprazole sodium, the sodium salt of esomeprazole which has the effect of reducing gastric acid secretion.

Synonyms: (S)-Omeprazole sodium; (-)-Omeprazole sodium; Esomeprazole(sodium)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Esomeprazole sodium

CAS No. :161796-78-7
Formula : C17H18N3NaO3S
M.W : 367.40
SMILES Code : O=[S@](C1=NC2=CC=C(OC)C=C2[N-]1)CC3=NC=C(C)C(OC)=C3C.[Na+]
Synonyms :
(S)-Omeprazole sodium; (-)-Omeprazole sodium; Esomeprazole(sodium)
MDL No. :MFCD07802816

Safety of Esomeprazole sodium

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H315-H318-H335-H410
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P362+P364-P403+P233-P501
Class:9
UN#:3077
Packing Group:

Isoform Comparison

Biological Activity

Description
Esomeprazole sodium ((S)-Omeprazole sodium) is a powerful and orally active inhibitor of the proton pump, decreasing acid production by targeting the H+, K+-ATPase in the gastric parietal cells. Furthermore, Esomeprazole sodium impedes exosome release by inhibiting V-H+-ATPases, acting as an exosome inhibitor[4].
Target
  • ATPase

In Vitro:

Cell Line
Concentration Treated Time Description References
Jurkat cells 5 μM 72 h Inhibit H+-ATPase activity and regulate intracellular pH Immunity. 2023 Dec 12;56(12):2682-2698.e9.
Het-1A cells 30 µM 6 h To evaluate the effect of Esomeprazole on HCl-induced inflammatory responses. Results showed that Esomeprazole significantly inhibited the HCl-induced elevation of pro-inflammatory cytokines (IL-6, IL-8, IL-1β, TNF-α). Front Immunol. 2024 Dec 16;15:1410904.
Human cord blood-derived mast cells 50μM 2 h To evaluate the effect of omeprazole on human mast cell degranulation and cytokine secretion. Results showed that omeprazole significantly inhibited LAMP-1 expression and histamine release. J Allergy Clin Immunol. 2020 Oct;146(4):884-893.e5.
Bone marrow-derived mast cells 50μM 2 h To evaluate the effect of omeprazole on IgE-mediated mast cell degranulation and cytokine secretion. Results showed that omeprazole significantly inhibited LAMP-1 expression and histamine release. J Allergy Clin Immunol. 2020 Oct;146(4):884-893.e5.
IPF lung fibroblasts 100 μM 24 h To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced collagen production. Results showed that the combination therapy significantly suppressed collagen production. Sci Rep. 2022 Nov 30;12(1):20668.
IPF lung fibroblasts 100 μM 48 h To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced collagen gel contraction. Results showed that the combination therapy effectively inhibited collagen gel contraction. Sci Rep. 2022 Nov 30;12(1):20668.
IPF lung fibroblasts 100 μM 72 h To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced cell migration. Results showed that the combination therapy was more effective in inhibiting cell migration than monotherapy. Sci Rep. 2022 Nov 30;12(1):20668.
IPF lung fibroblasts 100 μM 24 h To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced cell proliferation. Results showed that esomeprazole significantly enhanced the anti-proliferative effect of pirfenidone. Sci Rep. 2022 Nov 30;12(1):20668.
Human esophageal adenocarcinoma cell line OE19 50 μM, 200 μM, 350 μM 72 h To evaluate the effect of esomeprazole on OE19 cell survival, showing dose-dependent inhibition of cell survival J Exp Clin Cancer Res. 2014 Sep 1;33(1):73.
Human esophageal squamous cell carcinoma cell line KYSE410 50 μM, 250 μM, 350 μM 72 h To evaluate the effect of esomeprazole on KYSE410 cell survival, showing dose-dependent inhibition of cell survival J Exp Clin Cancer Res. 2014 Sep 1;33(1):73.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Intragastric administration model Intragastric administration 50 pellets Single dose, lasting 2 hours Observe the structural changes of esomeprazole magnesium enteric-coated pellets in the stomach. Results showed that the retention rate of pellets in the stomach after 2 hours was 38.97%, and the sphericity, pellet volume, pore volume, and porosity were 0.47, 1.55×10^8 mm3, 0.44×10^8 mm3, and 27.6%, respectively. Acta Pharm Sin B. 2022 Jan;12(1):326-338
BALB/c mice Whole-brain irradiation injury model Intraperitoneal injection 10 mg/kg Once daily for 8 weeks Inhibited AEP’s enzymatic activity and alleviated radiation-induced brain injury iScience. 2024 Apr 9;27(5):109698
Mice Radiation-induced brain injury model Intraperitoneal injection 10 mg/kg Once daily for 8 weeks Inhibited the enzymatic activity of AEP and alleviated radiation-induced brain injury iScience. 2024 Apr 9;27(5):109698
BALB/c mice Passive systemic anaphylaxis model Intraperitoneal injection 1.6mg/0.2mL 4 consecutive days To evaluate the effect of esomeprazole on IgE-mediated systemic anaphylaxis. Results showed that esomeprazole significantly reduced the drop in core body temperature and release of MCPT-1 and histamine. J Allergy Clin Immunol. 2020 Oct;146(4):884-893.e5.
C57BL/6J mice TGFβ-induced lung fibrosis model Oral gavage 30 mg/kg Daily administration for 28 days To evaluate the effect of esomeprazole combined with pirfenidone on TGFβ-induced lung fibrosis. Results showed that the combination therapy was more effective in suppressing lung fibrosis and αSMA expression than monotherapy. Sci Rep. 2022 Nov 30;12(1):20668.
Mice Clostridioides difficile infection model Oral gavage 40 mg/kg Five times per 12 h interval Used to induce Clostridioides difficile infection model, results showed Esomeprazole pretreatment increased infection risk. Bioeng Transl Med. 2023 Sep 5;8(6):e10593
Mice B16-F10 melanoma model Intraperitoneal injection 12.5 mg/kg Every other day for a total of 6 injections Neutralize tumor microenvironment acidic pH and improve T cell function Immunity. 2023 Dec 12;56(12):2682-2698.e9.
Mice Autism spectrum disorder model Oral 50 mg/kg 4 weeks To investigate the effects of p-Cresol on ASD-like behaviors in mice, results showed p-Cresol induced social behavior deficits and stereotypies Microbiome. 2021 Jul 8;9(1):157

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03383003 Helicobacter Pylori Infection Not Applicable Completed - Taiwan ... More >> Wei-Chen Tai Kaohsiung, Taiwan, 833 Less <<
NCT02711176 Helicobacter Infection Phase 4 Completed - Iran, Islamic Republic of ... More >> Ilam University of Medical Scienvc Ilam, Iran, Islamic Republic of, 6939177143 Less <<
NCT03444402 GERD Phase 1 Completed - Korea, Republic of ... More >> Seoul University Hospital Seoul, Korea, Republic of Less <<
NCT02197039 - Unknown July 2016 Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Hsiu-Chi Cheng, MD, PhD    886-6-2353535 ext 4733    teishuki@mail.ncku.edu.tw    Principal Investigator: Hsiu-Chi Cheng, MD, PhD Less <<
NCT00881413 Peptic Ulcer Phase 4 Withdrawn(problems in funding) - -
NCT03488147 Dysphagia GER... More >>D Degenerative Joint Disease Less << Phase 2 Not yet recruiting April 2, 2020 United States, New York ... More >> Mount Sinai West Not yet recruiting New York, New York, United States, 10019 Principal Investigator: Andrew C Hecht, MD          Icahn School of Medicine at Mount Sinai Not yet recruiting New York, New York, United States, 10029 Principal Investigator: Andrew C Hecht, MD Less <<
NCT00444236 Exercise Triggered Asthma ... More >> Gastroesophageal Reflux Less << Phase 1 Terminated(The sponsor decided... More >> to terminate the study due to slow enrollment.) Less << - United States, Utah ... More >> University of Utah Health Sciences Center Salt Lake City, Utah, United States, 84132 Less <<
NCT01761513 Healthy Phase 1 Completed - Korea, Republic of ... More >> Yonsei University Health System(Severance Hospital) Seoul, Seodaemun-gu,Sinchon-dong, Korea, Republic of, 120-752 Less <<
NCT00251966 Gastroesophageal Reflux Phase 3 Completed - -
NCT00123656 Esophagitis Phase 2 Completed - United States, Utah ... More >> University of Utah HSC Salt Lake City, Utah, United States, 84132 Less <<
NCT01669811 Refractory Reflux Esophagitis Phase 3 Completed - -
NCT02553083 Bacterial Infection Due to Hel... More >>icobacter Pylori (H. Pylori) Less << Phase 4 Recruiting December 2021 Israel ... More >> Rabin Medical Center Recruiting Petach Tikva, Israel, 49100 Contact: Yaron Niv, MD    97239377237    yniv@clalit.org.il    Principal Investigator: Yaron Niv, MD Less <<
NCT00079833 Zollinger-Ellison Syndrome Phase 3 Completed - United States, California ... More >> Research Site Los Angeles, California, United States United States, Florida Research Site Gainesville, Florida, United States United States, Ohio Research Site Columbus, Ohio, United States United States, Pennsylvania Research Site King of Prussia, Pennsylvania, United States Research Site Philadelphia, Pennsylvania, United States France Research Site Clichy, France Research Site Paris, France Research Site Saint Germain en Laye, France Less <<
NCT02794844 Gastroesophageal Reflux Phase 4 Completed - United States, Florida ... More >> Nemours Children's Hospital Orlando, Florida, United States, 32827 Less <<
NCT03040817 Gastric Peroral Endoscopic Pyl... More >>oromyotomy (G-POEM) Less << Not Applicable Recruiting December 16, 2019 China, Jiangsu ... More >> Zhongda Hospital Southeast University Recruiting Nanjing, Jiangsu, China Contact: Ruihua Shi       ruihuashi@126.com Less <<
NCT02794844 - Completed - -
NCT00241501 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 3 Completed - -
NCT00625274 Heartburn Upp... More >>er Abdominal Pain Nausea Acid Regurgitation Less << Phase 4 Completed - -
NCT02708355 - Completed - -
NCT01089959 Gastroesophageal Reflux Diseas... More >>e Less << Phase 2 Phase 3 Unknown March 2012 United States, Arizona ... More >> Southern Arizona VA Health Care System Recruiting Tucson, Arizona, United States, 85723 Contact: Ronnie Fass, MD    520-792-1450 ext 5139    ronniefass@va.gov    Principal Investigator: RONNIE FASS, MD Less <<
NCT02197143 Dyspepsia Phase 4 Completed - Turkey ... More >> Pamukkale Universty Denizli, Turkey, 20000 Less <<
NCT01669811 - Completed - -
NCT00251992 Gastrointestinal Disease ... More >> Signs and Symptoms, Digestive Dyspepsia Less << Phase 3 Completed - -
NCT00251914 Gastrointestinal Disease ... More >> Signs and Symptoms, Digestive Dyspepsia Less << Phase 3 Completed - -
NCT00951431 Nonulcer Dyspepsia Phase 4 Unknown December 2011 Hong Kong ... More >> Prince of Wales Hospital Recruiting Hong Kong, Hong Kong Principal Investigator: Justin C.Y. Wu, MBChB(CUHK) Less <<
NCT03558477 GERD Phase 1 Completed - Korea, Republic of ... More >> Kyungpook national university hospital Daegu, Korea, Republic of Less <<
NCT02708355 Heartburn Phase 4 Completed - United States, Oklahoma ... More >> Oklahoma Foundation for Digestive Research Oklahoma City, Oklahoma, United States, 73102 St. Anthony Hospital - Conference Rooms Oklahoma City, Oklahoma, United States, 73102 Less <<
NCT00164788 Gastrointestinal Hemorrhage Phase 2 Terminated(No suitable patient... More >>s and many patients refused the study) Less << - China ... More >> Endoscopy Center, Prince of Wales Hospital Hong Kong (SAR), China Less <<
NCT02476097 Stomach Diseases Phase 4 Recruiting December 2018 Switzerland ... More >> Service de de médecine interne et de rehabilitation, Beau-séjour, HUG Recruiting Genève, Switzerland Contact: Jules Desmeules, Pr    41(0)22 23 05 53 87       Principal Investigator: Jules Desmeules, Pr          Service de réadaptation de l'appareil locomoteur Clinique romande de réadaptation, Sion Recruiting Sion, Switzerland Contact: Lucien Roulet, Pharm D       lucien.roulet@hopitalvs.ch Less <<
NCT00069823 Asthma Lung D... More >>iseases Lung Diseases, Obstructive Less << Phase 3 Completed - -
NCT00230516 Healthy Phase 4 Completed - United States, California ... More >> Research Site Los Angeles, California, United States United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States Less <<
NCT00069823 - Completed - -
NCT00628342 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 4 Completed - -
NCT00361985 Anastomotic Stricture ... More >> Morbid Obesity Less << Phase 4 Withdrawn(Insufficient enrollm... More >>ent) Less << - United States, New York ... More >> Weill Medical College of Cornell Unversity New York, New York, United States, 10021 Less <<
NCT01123031 Upper Gastrointestinal Bleedin... More >>g Less << Phase 4 Unknown April 2011 -
NCT00444275 GERD Phase 4 Completed - France ... More >> Research Site Rouen, France Less <<
NCT00628667 Chronic Posterior Laryngitis (... More >>CPL) Less << Phase 4 Completed - -
NCT00222079 Gastro-esophageal Reflux Not Applicable Terminated(Project canceled du... More >>e to the implementation of IMRT, fewer patients reporting xerostomia.) Less << - United States, Iowa ... More >> University of Iowa Department of Otolaryngology Iowa City, Iowa, United States, 52242 Less <<
NCT00444275 - Completed - -
NCT00574925 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 4 Completed - Switzerland ... More >> University Hospital Zurich Zurich, Switzerland Less <<
NCT00728481 Eosinophilic Esophagitis ... More >> Gastroesophageal Reflux Disease EE GERD Less << Phase 2 Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01275937 Upper Gastrointestinal Bleedin... More >>g Less << Phase 4 Unknown January 2014 Taiwan ... More >> Taipei Medical University Hospital Recruiting Taipei, Taiwan, 110 Contact: Hwai-jeng Lin, M.D.    886-2-27372181 ext 3040    buddhistlearning@gmail.com    Principal Investigator: Hwai-jeng Lin, M.D. Less <<
NCT00644735 Erosive Esophagitis Phase 4 Completed - -
NCT00728481 - Completed - -
NCT00626535 Symptomatic Gastroesophageal R... More >>eflux Disease (sGERD) Less << Phase 3 Completed - -
NCT00612027 - Completed - -
NCT00332748 Cancer Phase 1 Terminated - United States, Delaware ... More >> Local Institution Newark, Delaware, United States United States, Kentucky Local Institution Louisville, Kentucky, United States United States, Nevada Local Institution Las Vegas, Nevada, United States Netherlands Local Institution Amsterdam, Netherlands Less <<
NCT03315676 Gastrointestinal Erosions and/... More >>or Ulcers Less << Phase 2 Recruiting September 4, 2020 Japan ... More >> Yukio Nakamura Recruiting Matsumoto, Nagano, Japan, 3908621 Contact: Yukio Nakamura, MD, PhD    +81-263-37-2659    yxn14@aol.jp    Principal Investigator: Yukio Nakamura, MD, PhD Less <<
NCT00317044 - Completed - -
NCT02277886 Gastroesophageal Reflux Diseas... More >>e Heartburn Sleep Disturbance Less << Phase 4 Unknown June 2016 Taiwan ... More >> Chang Gung Memorial Hospital Recruiting Taipei, Taiwan, 105 Contact: Cheng-Tang Chiu, MD    +886-3-3281200 ext 8101    stacey@adm.cgmh.org.tw    Contact: Johnny Chu, PhD    +886-2-25090464 ext 4280    johnnychu@tty.com.tw    Principal Investigator: Cheng-Tang Chiu, MD Less <<
NCT00474019 Pharmacokinetics Phase 1 Completed - United States, Arkansas ... More >> Research Site Little Rock, Arkansas, United States United States, Connecticut Research Site Hartford, Connecticut, United States United States, Illinois Research Site Park Ridge, Illinois, United States United States, Kentucky Research Site Louisville, Kentucky, United States United States, Michigan Research Site Detroit, Michigan, United States Research Site Southfield, Michigan, United States United States, New Jersey Research Site New Brunswick, New Jersey, United States United States, New York Research Site Buffalo, New York, United States United States, Ohio Research Site Cleveland, Ohio, United States United States, Texas Research Site Fort Worth, Texas, United States Research Site Houston, Texas, United States Australia, South Australia Research Site North Adelaide, South Australia, Australia Belgium Research Site Brussels (jette), Belgium Hungary Research Site Budapest, Hungary Sweden Research Site Goteborg, Sweden Less <<
NCT00317044 Asthma GERD Phase 2 Completed - -
NCT02543606 Healthy Phase 4 Completed - Taiwan ... More >> Taichung Veterans General Hospital Taichung, Taiwan, 40705 Less <<
NCT00660660 Gastroesophageal Reflux Diseas... More >>e Less << Phase 4 Completed - -
NCT00684190 Gastroesophageal Reflux Diseas... More >>e Less << Phase 1 Completed - Sweden ... More >> Research Site Uppsala, Sweden Less <<
NCT00660660 - Completed - -
NCT00629564 GERD Phase 4 Completed - -
NCT00633412 NSAID Associated Gastric Ulcer... More >>s Less << Phase 3 Completed - -
NCT00287339 - Completed - -
NCT00225238 Nausea Vomiti... More >>ng Abdominal Pain Less << Phase 4 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00287339 Cough GERD Phase 4 Completed - United States, North Carolina ... More >> UNC Gastroenterology, UNC Pulmonology, UNC ENT Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00628953 Asthma Phase 2 Completed - -
NCT00318968 GERD Phase 4 Completed - Denmark ... More >> Research Site Aabenraa, Denmark Research Site Aalborg, Denmark Research Site Albek, Denmark Research Site Alborg, Denmark Research Site Ans by, Denmark Research Site Arhus C, Denmark Research Site Bagsverd, Denmark Research Site Birkerod, Denmark Research Site Bronshoj, Denmark Research Site Farum, Denmark Research Site Fredericia, Denmark Research Site Frederikshavn, Denmark Research Site Frederikssund, Denmark Research Site Grasten, Denmark Research Site Haslev, Denmark Research Site Herning, Denmark Research Site Hinnerup, Denmark Research Site Karlslunde, Denmark Research Site Kerteminde, Denmark Research Site Kobenhavn K, Denmark Research Site Kolding, Denmark Research Site Losning, Denmark Research Site Middelfart, Denmark Research Site Nestved, Denmark Research Site Odense C, Denmark Research Site Randers, Denmark Research Site Rodovre, Denmark Research Site Roskilde, Denmark Research Site Rungsted Kyst, Denmark Research Site Saltum, Denmark Research Site Seby, Denmark Research Site Sindal, Denmark Research Site Solrod Strand, Denmark Research Site Svendborg, Denmark Research Site Tastrup, Denmark Research Site Tonder, Denmark Research Site Ullerslev, Denmark Research Site Viborg, Denmark Research Site Viby J, Denmark Less <<
NCT00216788 Reflux Esopha... More >>gitis Barrett's Esophagus Less << Phase 1 Unknown January 2006 United States, Pennsylvania ... More >> Lankenau Hospital Not yet recruiting Wynnewood, Pennsylvania, United States, 19096 Contact: Daniel Lazowick, D.O.    610-645-6555       Sub-Investigator: Daniel Lazowick, D.O. Less <<
NCT00295685 GERD Phase 4 Completed - United States, Virginia ... More >> Digestive & Liver Disease Specialists Norfolk, Virginia, United States, 23502 Less <<
NCT02444507 Healthy Adult Subjects Phase 4 Unknown June 2015 Taiwan ... More >> Taichung Veterans General Hospital Recruiting Taichung City, Taiwan, 40705 Contact: Yeh Hong Zen, Physician    886-919085331    yhz@vghtc.gov.tw    Sub-Investigator: Chen Chia Chang, Physician Less <<
NCT00635414 GERD Phase 4 Completed - -
NCT00637988 Barrett's Esophagus Phase 4 Completed - -
NCT00251927 Gastroesophageal Reflux Phase 3 Completed - -
NCT02494856 Pain Other Su... More >>rgical Procedures Impacted Third Molar Tooth Less << Phase 4 Completed - Brazil ... More >> University of São Paulo Bauru, SP, Brazil, 17012-901 Less <<
NCT01130935 - Completed - Albania ... More >> Research Site Berat, Albania Research Site Burrel, Albania Research Site Durres, Albania Research Site Elbasan, Albania Research Site Fier, Albania Research Site Kavaje, Albania Research Site Korce, Albania Research Site Kruje, Albania Research Site Lezhe, Albania Research Site Lushnje, Albania Research Site Peshkopi, Albania Research Site Shkoder, Albania Research Site Tirane, Albania Research Site Vlore, Albania Less <<
NCT00443963 Dyspepsia Phase 4 Terminated(The Principal Inves... More >>tigator is no longer affiliated with the Study Site.) Less << - United States, District of Col... More >>umbia Washington Hospital Center 110 Irving St. NW, Washington, District of Columbia, United States, 20010 Less <<
NCT01591083 Peptic Ulcer Bleeding Phase 4 Completed - Taiwan ... More >> National Cheng Kung University Hospital Tainan, Taiwan, 704 Less <<
NCT01153659 Healthy Phase 1 Completed - United States, Oklahoma ... More >> Oklahoma Foundation for Digestive Research Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00405119 Gastroesophageal Reflux Diseas... More >>e Reflux, Gastroesophageal Less << Phase 2 Completed - Australia, New South Wales ... More >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Herston, Queensland, Australia, 4006 Less <<
NCT00629512 NSAID Associated Gastric Ulcer... More >>s Less << Phase 3 Completed - -
NCT00629928 NSAID Associated Gastric Ulcer... More >>s Less << Phase 3 Completed - -
NCT00251927 - Completed - -
NCT03211143 GERD Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of Less <<
NCT01199328 Healthy Volunteers Phase 1 Completed - United States, Missouri ... More >> Research Site Springfield, Missouri, United States Less <<
NCT00206024 Heartburn Phase 4 Completed - -
NCT00318084 GERD Phase 4 Completed - Netherlands ... More >> Research Site Utrecht, Netherlands Less <<
NCT00474903 - Completed - -
NCT00474903 Barrett Esophagus ... More >> Esophageal Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00184522 Gastroesophageal Reflux Phase 4 Completed - Norway ... More >> Gjøvik Specialist Centre Gjøvik, Norway, 2800 Sykehuset Innlandet HF, Gjøvik Gjøvik, Norway, 2819 Sykehuset Innlandet HF, Hamar Hamar, Norway Sykehuset Innlandet HF, Kongsvinger Kongsvinger, Norway Sykehuset Innlandet HF, Lillehammer Lillehammer, Norway Helse Nord-Møre og Romsdal Molde, Norway Mosjøen sykehus Mosjøen, Norway Helse Nord-Trøndelag Namsos, Norway Sykehuset Innlandet HF, Tynset Tynset, Norway Less <<
NCT01471925 Gastroesophageal Reflux Diseas... More >>e Less << Phase 3 Withdrawn(Change company strat... More >>egy) Less << - Brazil ... More >> Instituto Goiano de Gastroenterologia Goiania, GO, Brazil Mãe de Deus Center Porto Alegre, Rio Grande do Sul, Brazil Centro de pesquisa Clínica do Serviço de gastroenterologia Rio de janeiro, RJ, Brazil Hospital Israelita Albert Einstein São Paulo, SP, Brazil Centro de Pesquisa Clínica de Campinas Canpinas, São Paulo, Brazil Centro de Estudos Clínicos do Interior Paulista Jaú, São Paulo, Brazil Less <<
NCT03562026 - Recruiting December 31, 2020 Japan ... More >> Research Site Recruiting Aichi, Japan Research Site Not yet recruiting Aichi, Japan Research Site Recruiting Akita, Japan Research Site Recruiting Chiba, Japan Research Site Not yet recruiting Chiba, Japan Research Site Recruiting Ehime, Japan Research Site Active, not recruiting Ehime, Japan Research Site Recruiting Fukui, Japan Research Site Recruiting Fukuoka, Japan Research Site Not yet recruiting Fukuoka, Japan Research Site Recruiting Gifu, Japan Research Site Not yet recruiting Gifu, Japan Research Site Active, not recruiting Gunma, Japan Research Site Recruiting Hiroshima, Japan Research Site Not yet recruiting Hiroshima, Japan Research Site Recruiting Hokkaido, Japan Research Site Recruiting Hyogo, Japan Research Site Not yet recruiting Hyogo, Japan Research Site Recruiting Ibaraki, Japan Research Site Not yet recruiting Iwate, Japan Research Site Recruiting Kagawa, Japan Research Site Recruiting Kagoshima, Japan Research Site Active, not recruiting Kanagawa, Japan Research Site Recruiting Kanagawa, Japan Research Site Not yet recruiting Kanagawa, Japan Research Site Recruiting Kumamoto, Japan Research Site Not yet recruiting Kyoto, Japan Research Site Recruiting Mie, Japan Research Site Recruiting Miyagi, Japan Research Site Active, not recruiting Miyagi, Japan Research Site Recruiting Nagano, Japan Research Site Active, not recruiting Nagano, Japan Research Site Not yet recruiting Okayama, Japan Research Site Recruiting Osaka, Japan Research Site Not yet recruiting Osaka, Japan Research Site Recruiting Saitama, Japan Research Site Recruiting Shizuoka, Japan Research Site Recruiting Tochigi, Japan Research Site Active, not recruiting Tokushima, Japan Research Site Recruiting Tokyo, Japan Research Site Not yet recruiting Tokyo, Japan Research Site Recruiting Toyama, Japan Research Site Recruiting Yamagata, Japan Less <<
NCT00633672 NSAID Associated Gastric Ulcer... More >>s Less << Phase 3 Completed - -
NCT00626262 Gastroesophageal Reflux Diseas... More >>e Less << Phase 4 Completed - -
NCT00734097 Gastroesophageal Reflux Diseas... More >>e Less << Phase 4 Completed - Argentina ... More >> Research Site Buenos Aires, Argentina Chile Research Site Santiago de Chile, Chile Research Site Temuco, Chile Research Site Vina del Mar, Chile Colombia Research Site Barranquilla, Colombia Research Site Bogota, Colombia Research Site Medellin, Colombia Venezuela Research Site Barquisimeto, Venezuela Research Site Caracas, Venezuela Research Site San Cristobal, Venezuela Less <<
NCT00734097 - Completed - -
NCT01562600 - Completed - Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less <<
NCT01729182 - Completed - Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less <<
NCT00637559 Barrett's Esophagus Phase 4 Completed - -
NCT02680119 Healthy Phase 1 Completed - -
NCT00625495 Gastroesophageal Reflux Diseas... More >>e Less << Phase 4 Completed - -
NCT01435525 - Completed - Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tokyo, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamanashi, Japan Less <<
NCT00206440 Nausea Phase 3 Terminated(Accrual was not opt... More >>imized) Less << - United States, Texas ... More >> Baylor Breast Center Houston, Texas, United States, 77030 Less <<
NCT01434485 - Completed - Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less <<
NCT01562639 - Completed - Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less <<
NCT00206180 Erosive Esophagitis ... More >> Reflux Esophagitis Gastroesophageal Reflux Disease Less << Phase 4 Completed - -
NCT00687245 Endoscopically-Proven GERD ... More >> Reflux Less << Phase 1 Completed - -
NCT00641602 Erosive Esophagitis Phase 4 Completed - -
NCT00428701 Gastric Ulcer Phase 4 Completed - United States, Delaware ... More >> Research SIte Newark, Delaware, United States United States, Louisiana Research Site Shreveport, Louisiana, United States United States, Pennsylvania Research Site Hershey, Pennsylvania, United States United States, Tennessee Research Site Memphis, Tennessee, United States Research Site Nashville, Tennessee, United States Less <<
NCT00699426 Type 2 Diabetes Phase 3 Completed - -
NCT02680132 Healthy Phase 1 Completed - -
NCT00206440 - Terminated(Accrual was not opt... More >>imized) Less << - -
NCT01129713 Gastroesophageal Reflux Diseas... More >>e (GERD) Heartburn Indigestion Less << Phase 1 Phase 2 Unknown May 2015 United States, Arizona ... More >> Southern Arizona Veterans Health Care System Recruiting Tucson, Arizona, United States, 85723 Principal Investigator: Ronnie Fass, MD Less <<
NCT01142128 Chronic Pancreatitis Phase 1 Terminated(Viokase was taken o... More >>ff market during study and remained off over a year.) Less << - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT01142128 - Terminated(Viokase was taken o... More >>ff market during study and remained off over a year.) Less << - -
NCT02659683 Healthy Subjects Phase 1 Completed - -
NCT02477475 - Completed - Japan ... More >> Research Site Aichi, Japan Research Site Akita, Japan Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukui, Japan Research Site Fukuoka, Japan Research Site Fukushima, Japan Research Site Gifu, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaraki, Japan Research Site Ishikawa, Japan Research Site Iwate, Japan Research Site Kagawa, Japan Research Site Kagoshima, Japan Research Site Kanagawa, Japan Research Site Kochi, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Mie, Japan Research Site Miyagi, Japan Research Site Miyazaki, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Niigata, Japan Research Site Oita, Japan Research Site Okayama, Japan Research Site Okinawa, Japan Research Site Osaka, Japan Research Site Saga, Japan Research Site Saitama, Japan Research Site Shiga, Japan Research Site Shimane, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokushima, Japan Research Site Tokyo, Japan Research Site Tottori, Japan Research Site Toyama, Japan Research Site Wakayama, Japan Research Site Yamagata, Japan Research Site Yamaguchi, Japan Research Site Yamanashi, Japan Less <<
NCT00637845 Heartburn Gas... More >>troesophageal Reflux Disease Less << Phase 4 Completed - -
NCT01135472 Healthy Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00658775 - Completed - -
NCT00658775 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 3 Completed - -
NCT00658632 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 3 Completed - -
NCT00658632 - Completed - -
NCT00658528 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 3 Completed - -
NCT00658528 - Completed - -
NCT02479581 Valvular Heart Disease Phase 2 Completed - China, Hunan ... More >> Xiangya Hospital of Central South University Changsha, Hunan, China, 410078 Less <<
NCT00464308 Gastro-oesophageal Reflux Phase 4 Completed - Australia ... More >> Belconnen, Australia Bondi Junction, Australia Brookvale, Australia Browns Plains, Australia Campbelltown, Australia Campsie, Australia Caringbah, Australia Castle Hill, Australia Charlestown, Australia Dapto, Australia Darlinghurst, Australia Dubbo, Australia Elizabeth, Australia Fairfield, Australia Hoppers Crossing, Australia Ingleburn, Australia Leichhardt, Australia Maroubra, Australia Melton, Australia Mount Druitt, Australia Oaklands Park, Australia Royal Park, Australia Sydney, Australia Wentworthville, Australia Wyoming, Australia Less <<
NCT03600974 - Not yet recruiting July 1, 2021 -
NCT00464308 - Completed - -
NCT03452865 Sepsis Septic... More >> Shock Less << Phase 3 Not yet recruiting June 2022 Italy ... More >> IRCCS San Raffaele Scientific Institute Not yet recruiting Milan, MI, Italy, 20132 Contact: Giacomo Monti, MD    +39 022643 2222    monti.giacomo@hsr.it Less <<
NCT00857597 Gastroesophageal Reflux Diseas... More >>e (GERD) Less << Phase 3 Terminated(Study was terminate... More >>d after unplanned interim analysis of single centre data and results were reported) Less << - Netherlands ... More >> University Hospital Maastricht Maastricht, Limburg, Netherlands, 6229 HX Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.72mL

0.54mL

0.27mL

13.61mL

2.72mL

1.36mL

27.22mL

5.44mL

2.72mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories